Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Biopoin

Biopoin 1,000 IU/0.5 ml solution for injection in pre-filled syringe Biopoin 2,000 IU/0.5 ml solution for injection in pre-filled syringe Biopoin 3,000 IU/0.5 ml solution for injection in pre-filled syringe Biopoin 4,000 IU/0.5 ml solution for injection in pre-filled syringe Biopoin 5,000 IU/0.5 ml solution for injection in pre-filled syringe Biopoin 10,000 IU/1 ml solution for injection in pre-filled syringe Biopoin 20,000 IU/1 ml solution for injection in pre-filled syringe Biopoin 30,000 IU/1 ml solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 8–9

HOS-210287 · Präparat HOS-154493

8  Table 1: Adverse reactions System organ class Adverse reaction Frequency Symptomatic anaemia Symptomatic anaemia associated with in cancer patients with chronic renal failure non-myeloid malignancies receiving chemotherapy Blood and lymphatic Pure red cell aplasia Not known — system disorders (PRCA)* Immune system Hypersensitivity Not known disorders reactions Nervous system Headache Common disorders Vascular disorders Hypertension* Common Hypertensive crisis* Common — Shunt thrombosis* Common — Thromboembolic — Not known events Skin and subcutaneous Skin reactions* Common tissue disorders Musculoskeletal and Arthralgia — Common connective tissue disorders General disorders and Influenza-like illness* Common administration site conditions *See subsection “Description of selected adverse reactions” below

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.